88 related articles for article (PubMed ID: 2006276)
1. Graves ophthalmopathy: role of MR imaging in radiation therapy.
Just M; Kahaly G; Higer HP; Rösler HP; Kutzner J; Beyer J; Thelen M
Radiology; 1991 Apr; 179(1):187-90. PubMed ID: 2006276
[TBL] [Abstract][Full Text] [Related]
2. Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements.
Ohnishi T; Noguchi S; Murakami N; Tajiri J; Harao M; Kawamoto H; Hoshi H; Jinnouchi S; Futami S; Nagamachi S
Radiology; 1994 Mar; 190(3):857-62. PubMed ID: 8115640
[TBL] [Abstract][Full Text] [Related]
3. Graves ophthalmopathy: MR imaging of the orbits.
Hosten N; Sander B; Cordes M; Schubert CJ; Schörner W; Felix R
Radiology; 1989 Sep; 172(3):759-62. PubMed ID: 2772184
[TBL] [Abstract][Full Text] [Related]
4. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
[TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance tomographic differentiation of ocular muscle changes in endocrine orbitopathy].
Hosten N; Cordes M; Sander B; Schörner W; Wenzel KW; Felix R
Rofo; 1990 Apr; 152(4):388-92. PubMed ID: 2160096
[TBL] [Abstract][Full Text] [Related]
6. [The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation].
Hosten N; Schörner W; Lietz A; Wenzel KW
Rofo; 1992 Sep; 157(3):210-4. PubMed ID: 1391813
[TBL] [Abstract][Full Text] [Related]
7. Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids.
Nakahara H; Noguchi S; Murakami N; Morita M; Tamaru M; Ohnishi T; Hoshi H; Jinnouchi S; Nagamachi S; Futami S
Radiology; 1995 Sep; 196(3):857-62. PubMed ID: 7644656
[TBL] [Abstract][Full Text] [Related]
8. [Results of nuclear magnetic resonance tomography studies in endocrine orbitopathy].
Pedrosa P; Pfannenstiel P; Just M; Higer HP; Utech C; Brederhoff J; Wulle KG
Klin Monbl Augenheilkd; 1988 Aug; 193(2):169-73. PubMed ID: 3184751
[TBL] [Abstract][Full Text] [Related]
9. Significance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathy.
Nishida Y; Tian S; Isberg B; Hayashi O; Tallstedt L; Lennerstrand G
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):515-20. PubMed ID: 12136278
[TBL] [Abstract][Full Text] [Related]
10. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.
Prummel MF; Gerding MN; Zonneveld FW; Wiersinga WM
Clin Endocrinol (Oxf); 2001 Feb; 54(2):205-9. PubMed ID: 11207635
[TBL] [Abstract][Full Text] [Related]
11. Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?
Szucs-Farkas Z; Toth J; Balazs E; Galuska L; Burman KD; Karanyi Z; Leovey A; Nagy EV
AJR Am J Roentgenol; 2002 Oct; 179(4):1005-10. PubMed ID: 12239055
[TBL] [Abstract][Full Text] [Related]
12. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
Utech CI; Khatibnia U; Winter PF; Wulle KG
Thyroid; 1995 Jun; 5(3):185-93. PubMed ID: 7580266
[TBL] [Abstract][Full Text] [Related]
13. Graves' disease of the orbit.
Weber AL; Dallow RL; Sabates NR
Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
[TBL] [Abstract][Full Text] [Related]
14. Rectus extraocular muscle paths and decompression surgery for Graves orbitopathy: mechanism of motility disturbances.
Abràmoff MD; Kalmann R; de Graaf ME; Stilma JS; Mourits MP
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):300-7. PubMed ID: 11818370
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining of normal and Graves' extraocular muscle.
Tallstedt L; Norberg R
Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Resonance evaluation of disease activity in Graves' ophthalmopathy: T2-time and signal intensity of extraocular muscles.
Majos A; Pajak M; Grzelak P; Stefańczyk L
Med Sci Monit; 2007 May; 13 Suppl 1():44-8. PubMed ID: 17507884
[TBL] [Abstract][Full Text] [Related]
17. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy.
Yokoyama N; Nagataki S; Uetani M; Ashizawa K; Eguchi K
Thyroid; 2002 Mar; 12(3):223-7. PubMed ID: 11952043
[TBL] [Abstract][Full Text] [Related]
18. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].
Rodríguez-González N; Pérez-Rico C; López-Para Giménez R; Arévalo-Serrano J; Del Amo García B; Calzada Domingo L; Flores Ruiz L; Blanco R
Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of extraocular muscle volume and exophthalmos reduction after radiation therapy to treat Graves' ophthalmopathy: A pilot study.
Kim M; Chang JH; Lee NK
Eur J Ophthalmol; 2021 Mar; 31(2):340-345. PubMed ID: 31496266
[TBL] [Abstract][Full Text] [Related]
20. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
Antoniazzi F; Zamboni G; Cerini R; Lauriola S; Dall'Agnola A; Tatò L
J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
